Aytu Biopharma Inc (NASDAQ:AYTU)
| 2.68 Delayed Data As of Sep 29 |  +0.01 / +0.37%Today’s Change | 1.38 Today|||52-Week Range 4.88 | -29.10% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 314.1K | 2.6M | 3.2M | 3.7M | |
| Cost of Goods Sold | 105.7K | 747.0K | 1.3M | 1.8M | ||
| Depreciation And Amortization | -- | 874.8K | 1.8M | 1.8M | ||
| Operating Expenses | Gross Income | 208.4K | 940.7K | 95.5K | 55.9K | |
| General Expenses | 9.4M | 15.1M | 19.0M | 17.1M | ||
| Research And Development | 4.1M | 6.3M | 1.3M | 167.6K | ||
| Total Operating Expenses | 9.5M | 16.8M | 22.1M | 20.7M | ||
| Non-Operating Expenses | Operating Income | -9.2M | -14.2M | -18.9M | -17.1M | |
| Extraordinary Credit | 0.00 | 0.00 | 151.3K | 4.0M | ||
| Extraordinary Charge | 0.00 | -8.5M | -1.3M | -2.6M | ||
| Interest Expense On Debt | 138.0K | 5.5M | 2.5M | 0.00 | ||
| Other Expenses | 0.00 | 0.00 | 0.00 | 5.5M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -9.3M | -28.2M | -22.5M | -10.2M | |
| Income Taxes | -28.7K | 0.00 | 0.00 | 0.00 | ||
| Net Income | -9.3M | -28.2M | -22.5M | -10.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 1.9K | 4.4K | 23.3K | 665.6K | |
| Shares To Calculate EPS Diluted | 1.9K | 4.4K | 23.3K | 665.6K | ||
| Earnings Per Share | EPS | -$4,032.06 | -$77,665.24 | -$19,320.00 | -$15.31 | |
| EPS Diluted | -$4,838.48 | -$6,471.85 | -$965.97 | -$15.31 | ||
